Medicine
Dextrose, Potassium chloride and Sodium chloride 25 g/0.745 g/1.125 g per 500 mL injection
Dextrose, Potassium chloride and Sodium chloride 25 g/0.745 g/1.125 g per 500 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Dextrose, Potassium chloride and Sodium chloride
- Brand
- Sold under the generic name
- Strength
- 25 g/0.745 g/1.125 g per 500 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 20 bags of 500 mL
- Manufacturer
- Fresenius Kabi
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 September 2022
- Identifiers
- RxCUI 1863973, 1863975DailyMed set ID f0cc6713-4d47-49be-8116-901c99002b6bNDC 65219-151Application ANDA212348
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 20 bag in 1 case / 500 mL in 1 bag | 65219-151-75 | Fresenius Kabi | 2 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 February 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dextrose, Potassium chloride and Sodium chloride
Clinical summary
Dextrose, Potassium chloride and Sodium chloride is a fixed-dose combination of an osmotic laxative and a potassium salt indicated as a source of water, electrolytes and calories. MedsAcross supplies Dextrose, Potassium chloride and Sodium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextrose, Potassium chloride and Sodium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Potassium Chloride in Dextrose and Sodium Chloride prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Dextrose, Potassium chloride and Sodium chloride 25 g/0.745 g/1.125 g per 500 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.